Of America Corp /De/ Bank Sells 412 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank sold 412 shares of the company’s stock in a transaction that occurred on Tuesday, April 3rd. The stock was sold at an average price of $26.83, for a total value of $11,053.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

HCA Healthcare Stock Performance

NYSE HCA opened at $342.25 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The firm has a market capitalization of $84.26 billion, a P/E ratio of 15.58, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The stock’s fifty day moving average is $324.53 and its two-hundred day moving average is $341.25. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the firm earned $5.90 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.84%. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter worth approximately $31,000. Tidemark LLC purchased a new position in shares of HCA Healthcare during the fourth quarter worth $36,000. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare during the 3rd quarter worth about $39,000. Activest Wealth Management increased its stake in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. increased its stake in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of several analyst reports. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Truist Financial lowered their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada reduced their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, Barclays cut their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.